Clinical Trials Logo
  1. Home
  2. PAD
  3. NCT03452293

SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients — SUPERSUBII  

PAD Clinical Trial

Official title:
SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients

Clinical Trial Summary

The study will evaluate the safety and efficacy of subintimal Supera stenting in complex de novo or re-occlusive CTO (TASC C-D) lesions in patients with CLI. This study will be performed based on a rigorous sample size calculation, which will allow us to have the statistical power to validate our conclusions and therefore establish the generalizability of this strategy.

Clinical Trial Description

The present study is designed as a prospective, open label, observational study. The study will collect information about the medical care patients receive during their planned procedure. No additional testing or procedures will be done. Patients elected for endovascular revascularization with SuperSub strategy will be asked their written consent to the use of their personal data. Revascularization will be performed as per standard procedure of the sites. After discharge all patients will attend clinic visits at 30 days (±14 days), 6 months (±30 days), 12 months (±30 days) and 24 months (±30 days). Angiographic follow-up will be performed only in symptomatic patients, as clinically indicated and with the aim for a new treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03452293
Study type Observational
Source EndoCore Lab s.r.l.
Contact
Status Completed
Phase
Start date March 7, 2018
Completion date March 28, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT03157531 - Safety and Effectiveness of B-Laser™ in Subjects Affected With Infrainguinal PAD N/A
Recruiting NCT03668353 - Recombinant SeV-hFGF2/dF Injection for PAOD Phase 1
Not yet recruiting NCT04108806 - Study of Peripheral Arterial Calcification N/A
Completed NCT02561299 - Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study N/A
Completed NCT01355406 - Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System N/A
Recruiting NCT06239493 - IVUS-Guided Treatment for Percutaneous Vascular Interventions
Active, not recruiting NCT00390767 - Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD) Phase 1/Phase 2
Completed NCT02907203 - Clinical Investigation of the GORE® Drug-Coated PTA Balloon Catheter (GORE® DCB Catheter)
Recruiting NCT03686228 - Treatment of No-option CLI by G-CSF-mobilized PB-MNC N/A
Recruiting NCT03683628 - Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC N/A
Active, not recruiting NCT04204564 - VISION and VQI Paclitaxel Safety Analysis
Terminated NCT01341340 - The ABSORB BTK (Below The Knee) Clinical Investigation N/A
Completed NCT03135535 - Micro-mobile Foot Compression and Diabetic Foot Phase 2
Recruiting NCT03900832 - Effects of Heating on Exercise Pressor Reflex in Peripheral Artery Disease: Exercise Ability Early Phase 1
Recruiting NCT05361967 - Tack Optimized Balloon Angioplasty Post-Market Study
Active, not recruiting NCT02500303 - Influence of Diabetes on Lower Limb Amputation N/A
Completed NCT03358355 - Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial Phase 1/Phase 2
Withdrawn NCT03516383 - Pulse Wave Velocity Imaging in the Assessment of PAD
Completed NCT03590769 - Arterial Imaging of Inflammation and Resolution After Endovascular Surgery Phase 1
Completed NCT01938391 - Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal N/A